SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-30
👔
IONIS PHARMACEUTICALS INC
@IONS_InsiderForm 4 Filing: Schneider Eugene Sells $3.7M of $IONS
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
IONIS PHARMACEUTICALS INC
Ticker: $IONS
Transaction Value
$3.7M
Price/Share: $70.97
transaction date
2026-06-26
Shares: 52,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schneider Eugene, holds the title of EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC.
On 2026-06-26, the insider transacted 52,000 shares.The shares were transacted at a weighted average price of $70.97 per share, resulting in a total market-relevant value of $3.7M.
Executive Summary Summary
Schneider Eugene (EVP, Chf Clinical Develop Ofcr) sold $3.7M of $IONS
Post-Transaction Position: 77,114 shares
SEC Accession No: 0000874015-26-000216 (CIK: 1838539)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.